Goals and conditions · Condition
Type 2 diabetes
ICD-10-CM E11.9
Diabetes from progressive loss of insulin secretion, usually with insulin resistance, diagnosed by A1C or plasma glucose.
Biomarkers
Start with the primary markers, then add the companions that change how the primary result reads. Each link cites its source.
Glucose, Two-Hour PostprandialPrimary marker
ADA diagnoses diabetes at a fasting plasma glucose of 126 mg/dL (7.0 mmol/L) or higher.
Tests: Labcorp 6, Quest Diagnostics 3, with ranges on the biomarker page
Hemoglobin A1cPrimary marker
ADA diagnoses diabetes at an A1C of 6.5% or higher and sets an A1C goal below 7% for many nonpregnant adults.
Tests: Labcorp 13, Quest Diagnostics 10, with ranges on the biomarker page
Alb/Creat Ratio, UrineCompanion marker
ADA assesses urine albumin-to-creatinine ratio at least annually in all people with type 2 diabetes.
Tests: Labcorp 8, Quest Diagnostics 2, with ranges on the biomarker page
eGFR Creat-Cyst CCompanion marker
ADA assesses eGFR at least annually in all people with type 2 diabetes.
Tests: Labcorp 3, Quest Diagnostics 5, with ranges on the biomarker page
Related
Sources
We list which biomarkers a named source connects to this condition; we do not diagnose it. Interpret your own results with a licensed clinician, or track them in Aumnivida.